相关实验视频

Updated: Jan 14, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

在BCMA导向的CAR T细胞治疗后,我们应该如何选择最佳的救援治疗?

Arvind Suresh¹, Darren Pan², Jodi Lipof²

¹Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

|October 17, 2025

概括

针对B细胞成熟抗原 (BCMA) 的化学抗原受体T细胞疗法 (CAR-T) 对复发性/耐药性多发性髓瘤显示出前景. 本综述探讨了挽救疗法和测序策略,以克服耐药性并改善结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
血液学血液学血液学

背景情况:

导向B细胞成熟抗原 (BCMA) 嵌合抗原受体T细胞疗法 (CAR-T) 已经彻底改变了复发性/耐药性多发性骨髓瘤 (RRMM) 治疗.
尽管CAR-T有效,但疾病复发仍然是大多数患者面临的重大挑战,原因是耐药机制.

研究的目的:

对BCMA导向CAR-T治疗后复发的患者,审查当前的救援治疗策略.
检查各种救援疗法的支持数据,并提出最佳治疗顺序.

主要方法:

对RRMM后BCMA CAR-T的救援疗法的文献综述.
临床数据和耐药机制的分析.
讨论潜在的治疗顺序策略.

主要成果:

目前正在研究多种救援策略,以解决BCMA CAR-T后的耐药性问题.
证据支持不同救援选项的有效性正在出现.
目前还没有明确的救援疗法测序指导方针.

结论:

优化救援疗法和测序对于改善BCMA CAR-T后RRMM患者的治疗结果至关重要.
需要进一步的研究来建立最终的治疗算法.
个性化方法可能是必要的,以最大限度地提高临床效益.

关键词:

这就是为什么BCMABCMABCMA.在GPRC5D中使用.多发性骨髓瘤是一种多发性骨髓瘤.仿真抗原受体T细胞 (CAR T细胞)这是一个复发的复发.挽救疗法是一种救援疗法.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...